H. Michael Shepard is VP & Chief Scientific Officer at HALOZYME THERAPEUTICS INC (HALO). They have made 1 open-market trade across 1 company since 2013, most recently 2013-08-19.
CIK 0001507433
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HALO | 13,198 | $1.6M |
Shares reported on the most recent Form 4, priced at the 2013-09-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HALO | SELL | 2013-08-19 | 2013-09-11 | $7.11 | $71K | -40.6% | -1.7% | -1.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.